Treatment of advanced gastric cancer with the regimen of etoposide,folinic acid and fluorouracil
- VernacularTitle:依托泊苷合用醛氢叶酸、氟尿嘧啶治疗32例晚期胃癌
- Author:
Yun FAN
;
Yiping ZHANG
;
Lin SUN
;
- Publication Type:Journal Article
- Keywords:
gastric tumor;
folinic acid;
fluorouracil;
etoposide;
drug therapy
- From:
China Oncology
1998;0(01):-
- CountryChina
- Language:Chinese
-
Abstract:
Purpose:To observe the response and tolerance to the regimen of etoposide,folinic acid and fluorouracil (ELF) in advanced gastric cancer. Methods:Thirty two patients with advanced gastric cancer received chemotherapy of ELF regimen(VP 16 100 mg iv d 1—3 ,CF 100—300 mg iv d 1—3,5 FU 750 1 000 mg iv d 1—3 Results:The overall response rate was 37.5% (12/32) and complete response rate was 3.1% (1/31), the partial response rate was 33.4% (11/32). The main toxicity was myelosuppression and alopecia. Leukopenia was observed in 81.6% of the patients, but grade 3 and 4 in only 12.5%. Anemia and throbopenia was observed in 21.8% and 35.1% of the patients respectively, alopecia in 100%. Other side effects were uncommon. Conclusions:This study shows that the regimen of ELF is effective and tolerable for treatment of advanced gastric cancer. [
